(Q34145676)

25014706

31 July 2017

title

Safety profile of extended-release niacin in the AIM-HIGH trial (English)

1 reference

31 July 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

4

Jerome L Fleg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2

William E Boden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jeffrey L Probstfield

7

object named as

Jeffrey L Probstfield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Todd J Anderson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Patrice Desvigne-Nickens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ruth McBride

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

AIM-HIGH Investigators

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

1 July 2014

1 reference

25014706

The New England Journal of Medicine

31 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

288-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

Effects of extended-release niacin with laropiprant in high-risk patients

11 June 2020

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156937

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156937

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156937

5 July 2018

Identifiers

DOI

10.1056/NEJMC1311039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014706%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

25014706

1 reference